NEW ORLEANS (MedPage Today) -- Intravenous iron supplementation failed to boost the benefits of erythropoiesis-stimulating agents (ESAs) in cancer patients with chemotherapy-induced anemia, according to data from the largest study of its kind.
ASH: IV Iron Fails Test in Cancer-Related Anemia (CME/CE)Courtesy MedPage Today Surgery Thu, 12/10/2009 - 09:58
NEW ORLEANS (MedPage Today) -- Intravenous iron supplementation failed to boost the benefits of erythropoiesis-stimulating agents (ESAs) in cancer patients with chemotherapy-induced anemia, according to data from the largest study of its kind. More related itemsNovel combined therapy extends life, diminishes pain...
Experimental cold cap may help cancer patients keep...
Anemia Warning Backs Medicare
|
Popular by tags WeekMonth |
Post new comment